
Anti-CD44 antibodies inhibit both mTORC1 and mTORC2: A new rationale supporting CD44-induced AML differentiation therapy
Gadhoum, S Z, Madhoun, N Y, Abuelela, A F, Merzaban, J SLangue:
english
Journal:
Leukemia
DOI:
10.1038/leu.2016.221
Date:
August, 2016
Fichier:
PDF, 5.26 MB
english, 2016